Navigation Links
Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort
Date:7/27/2010

LONG BRANCH, N.J., July 27 /PRNewswire/ -- For the first time ever, large numbers of personnel from the world's largest pharmaceutical companies have been registering to attend Pharma ChemOutsourcing at the Jersey Shore this fall. Most are chemists by training and work in the exploding field of outsourcing/sourcing active pharmaceutical ingredients (API's).

Pharma ChemOutsourcing has found a home on the East Coast where the majority of the large pharmaceutical companies and their suppliers are located. "We have good working relationships with Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly, Roche, GSK, and Novartis, for example, and they often provide guidance to make the show more relevant to their current needs," Alexay continued. "We get a lot of input".

"The event is growing at a 35% rate this year," says Mark Alexay the event organizer, "but what distinguishes this year's attendance is that the large pharma companies are coming in much greater numbers than years past. This is evident in the sharply higher turnout from the respective companies. The Big Pharma attendees say that it's a convenient place to accomplish several high priority goals in a short period of time – there's a LOT of information in the conference sessions plus they meet their suppliers."

The event features 4 parallel tracks over 3 days, 150 speakers, 100 exhibitors, 1000 attendees, and is studded with nightly socializing events on the beach for effective networking. "People set up meetings before the show but the evening parties over several nights help people make new connections. It's much easier to approach someone new in a social setting away from the conference hotel," remarked Alexay.

The 2010 attendee list may be viewed at http://chemoutsourcing.com/attendees.php

The 100 exhibitors are at http://chemoutsourcing.com/sponsors.php

The 2009 Beach Party can be viewed at http://www.youtube.com/watch?v=zTGzZhqDjcU&feature=fvw

For additional information about the extravaganza chemistry event visit www.chemoutsourcing.com or contact Mark Alexay at +1-201-452-4023, or malexay@chemoutsourcing.com


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of innovative ... announced that Vincent J. Angotti has ... of the company,s board of directors, effective Monday, ... decades of experience leading executive and commercial teams ...
(Date:2/16/2017)... , Feb. 16, 2017 HealthInfoNet (HIN), ... it is partnering with Orion Health on the implementation of ... Maine residents, clinical information and is ... over 500 ambulatory care sites. Pending final review ... Health,s Amadeus , a precision medicine platform that leverages ...
(Date:2/16/2017)... 16, 2017 Die Stärkung ... haben in der Medizinproduktebranche oberste Priorität. Während die ... den Blick auf unmittelbar anstehende regulatorische Änderungen auf ... diesen Regionen. ... Aufsichtsbehörden, Hersteller von ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to ... other Butler products. Ken was impressed with the safety and reliability of the ... product on his show. This endorsement by Ken Matthews can be heard on ...
(Date:2/18/2017)... ... 2017 , ... Park Cities Pet Sitter President, Joette White, has been featured ... network. The episode, which was posted this week, features a 30-minute interview of ... Park Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s ...
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... has not kept pace. Enovate Medical has introduced an innovative workstation designed to ... of supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy ... electronic prescribing of controlled and non-controlled substances plus the ability to manage orders ... the United States now accept electronic prescriptions, according to the Office of the ...
Breaking Medicine News(10 mins):